CAPGEMINI : Invest Securities reassured by Accenture
"After performing rather well at the start of the year, the stock has underperformed over the last three months (-14 points), impacted by fears of a delayed market recovery following comments from certain US players", the analyst points out.
In his opinion, Accenture's publication 'contradicts these concerns, with the US giant's leading indicators pointing to a low point reached at the beginning of 2024, and a recovery that should accelerate over the coming months'.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.
Go to the original article.
Contact us to request a correction